Literature DB >> 9109446

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.

M Navab1, S Hama-Levy, B J Van Lenten, G C Fonarow, C J Cardinez, L W Castellani, M L Brennan, A J Lusis, A M Fogelman, B N La Du.   

Abstract

We have examined the effects of mildly oxidized LDL and atherosclerosis on the levels of two proteins associated with HDL; apolipoprotein J (apoJ), and paraoxonase (PON). On an atherogenic diet, PON activity decreased by 52%, and apoJ levels increased 2.8-fold in fatty streak susceptible mice, C57BL/6J (BL/6), but not in fatty streak resistant mice, C3H/HeJ (C3H). Plasma PON activity was also significantly decreased, and apoJ levels were markedly increased in apolipoprotein E knockout mice on the chow diet, resulting in a 9.2-fold increase in the apoJ/PON ratio as compared to controls. Furthermore, a dramatic increase in the apoJ/PON ratio (over 100-fold) was observed in LDL receptor knockout mice when they were fed a 0.15%-cholesterol-enriched diet. Injection of mildly oxidized LDL (but not native LDL) into BL/6 mice (but not in C3H mice) on a chow diet resulted in a 59% decrease in PON activity (P < 0.01) and a 3.6-fold increase in apoJ levels (P < 0.01). When an acute phase reaction was induced in rabbits, or the rabbits were placed on an atherogenic diet, hepatic mRNA for apoJ was increased by 2.7-fold and 2.8-fold, respectively. Treatment of HepG2 cells in culture with mildly oxidized LDL (but not native LDL) resulted in reduced mRNA levels for PON (3.0-fold decrease) and increased mRNA levels for apoJ (2.0-fold increase). In normolipidemic patients with angiographically documented coronary artery disease who did not have diabetes and were not on lipid-lowering medication (n = 14), the total cholesterol/HDL cholesterol ratio was 3.1+/-0.9 as compared to 2.9+/-0.4 in the controls (n = 19). This difference was not statistically significant. In contrast, the apoJ/PON ratio was 3.0+/-0.4 in the patients compared to 0.72+/-0.2 in the controls (P < 0.009). In a subset of these normolipidemic patients (n = 5), the PON activity was low (48+/-6.6 versus 98+/-17 U/ml for controls; P < 0.009), despite similar normal HDL levels, and the HDL from these patients failed to protect against LDL oxidation in co-cultures of human artery wall cells. We conclude that: (a) mildly oxidized LDL can induce an increased apoJ/PON ratio, and (b) the apoJ/PON ratio may prove to be a better predictor of atherosclerosis than the total cholesterol/HDL cholesterol ratio.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109446      PMCID: PMC508026          DOI: 10.1172/JCI119369

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Modification of the Recalde method for the isolation of human monocytes.

Authors:  A M Fogelman; F Elahi; K Sykes; B J Van Lenten; M C Territo; J A Berliner
Journal:  J Lipid Res       Date:  1988-09       Impact factor: 5.922

3.  Paraoxonase: another factor in NIDDM cardiovascular disease.

Authors:  M I Mackness; P N Durrington
Journal:  Lancet       Date:  1995-09-30       Impact factor: 79.321

Review 4.  The oxidation hypothesis of atherosclerosis.

Authors:  J L Witztum
Journal:  Lancet       Date:  1994-09-17       Impact factor: 79.321

5.  Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.

Authors:  J McElveen; M I Mackness; C M Colley; T Peard; S Warner; C H Walker
Journal:  Clin Chem       Date:  1986-04       Impact factor: 8.327

Review 6.  Clusterin: physiologic and pathophysiologic considerations.

Authors:  M E Rosenberg; J Silkensen
Journal:  Int J Biochem Cell Biol       Date:  1995-07       Impact factor: 5.085

7.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Authors:  Z S Galis; G K Sukhova; M W Lark; P Libby
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Authors:  D J Gordon; J L Probstfield; R J Garrison; J D Neaton; W P Castelli; J D Knoke; D R Jacobs; S Bangdiwala; H A Tyroler
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

9.  Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

Authors:  A D Watson; M Navab; S Y Hama; A Sevanian; S M Prescott; D M Stafforini; T M McIntyre; B N Du; A M Fogelman; J A Berliner
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

Authors:  R A Hegele; J H Brunt; P W Connelly
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-01       Impact factor: 8.311

View more
  54 in total

Review 1.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

2.  The role of 'paraoxonase-1 activity' as an antioxidant in coronary artery diseases.

Authors:  Maharudra Shekhanawar; Sarala M Shekhanawar; D Krisnaswamy; V Indumati; D Satishkumar; V Vijay; T Rajeshwari; M Amareshwar
Journal:  J Clin Diagn Res       Date:  2013-07-01

Review 3.  Anti-inflammatory properties of HDL.

Authors:  Benjamin J Ansell; Mohamad Navab; Karol E Watson; Gregg C Fonarow; Alan M Fogelman
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

4.  Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10-residue class G(*) apolipoprotein J peptide using solution NMR.

Authors:  Vinod K Mishra; Mayakonda N Palgunachari; Jason S Hudson; Ronald Shin; Tamara D Keenum; N Rama Krishna; G M Anantharamaiah
Journal:  Biochim Biophys Acta       Date:  2010-10-21

Review 5.  The paraoxonase gene family and atherosclerosis.

Authors:  David Seo; Pascal Goldschmidt-Clermont
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

Review 6.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

Review 7.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

8.  Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.

Authors:  S A Pereira; J R Batuca; U Caixas; T Branco; J Delgado-Alves; I Germano; F Lampreia; E C Monteiro
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 9.  The role of dysfunctional HDL in atherosclerosis.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; G M Anantharamaiah; Alan M Fogelman
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

10.  Is alcohol beneficial or harmful for cardioprotection?

Authors:  Raj Lakshman; Mamatha Garige; Maokai Gong; Leslie Leckey; Ravi Varatharajalu; Samir Zakhari
Journal:  Genes Nutr       Date:  2010-06       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.